Normally, your stomach and intestines digest the carbohydrate in your food into a sugar called glucose. Glucose is your body’s main source of energy. After digestion, the glucose moves into your blood to give your body energy. 

Women who are able to effectively manage their gestational diabetes and keep blood glucose levels in a safe range dramatically reduce the risk of complications for both themselves and their baby.

The potential complications of uncontrolled gestational diabetes include:

Approximately 7% of all pregnancies are complicated by GDM, resulting in more than 200,000 cases annually. The prevalence may range from 1 to 14% of all pregnancies, depending on the population studied and the diagnostic tests employed.

According to recent research from Brazil, “The capacity to increase glomerular filtration rate in response to an acute oral protein load is known as the renal functional reserve; the loss of such capacity is used as a marker of hyperfiltration. This physiological response in obese hypertensives is not yet fully understood.”

According to a study from the United States, “Laparoscopic adjustable gastric banding (LAGB) and laparoscopic Roux-en-Y gastric bypass (LRYGBP) both effectively treat the insulin resistance associated with type 2 diabetes mellitus (T2DM). Restriction of caloric consumption, alterations in the entero-insular axis or weight loss may contribute to lowering insulin resistance after these procedures.”

In a recently published article, scientists in the United States conducted a study “to evaluate the effects of improved glycaemic control on the abdominal visceral and subcutaneous fat in type 1 diabetes. Sixteen subjects were enrolled for this 6-month study. The goal was to achieve normal haemoglobin A1c (HbA1c <5.6% in our laboratory).”

A.N. Jacob and colleagues at the University of Texas described, “T1-weighted magnetic resonance imaging was used to measure the abdominal subcutaneous and visceral fat areas at the L2-L3 disk level. Activity and energy intake were assessed using a weekly recall and food diary respectively. Plasma leptin, ghrelin and adiponectin levels were measured at baseline and at 6 months.”

“Evidence suggests that women with type 2 diabetes may be at increased risk of breast cancer, possibly due to chronic exposure to insulin resistance and/or hyperinsulinemia. The purpose of this study was to compare the incidence of breast cancer in postmenopausal women with and without diabetes,” researchers in Canada report.

L.L. Lipscombe and colleagues of the Institute for Clinical Evaluative Sciences explained, “Using population-based validated health databases from Ontario, Canada, this retrospective cohort study compared breast cancer incidence between women, aged 55-79 years, with newly diagnosed diabetes (n=73,796) to women without diabetes (n=391,714). Women with diabetes were slightly older, were more likely to reside in a lower income neighborhood, had greater comorbidity, and had more annual physician visits than women without diabetes.”

According to research from the United States, “The inflammatory factor C-reactive protein (CRP) and the fibrinolytic variables fibrinogen and plasminogen activator-1 (PAI-1) are associated with long-term cardiovascular morbidity. To determine the contribution of body adiposity (BMI), insulin sensitivity (homeostasis model assessment of insulin resistance [HOMA-IR], and glycemia (HbA1c [A1C]) to the levels of these inflammatory and fibrinolytic variables in recently diagnosed ({{<=}}3 years), drug-naive, type 2 diabetic subjects (fasting plasma glucose {{<=}}10 mmol/L), we examined a representative subgroup (n=921) of the U.S. cohort in ADOPT (A Diabetes Outcome Progression Trial).”